Narus Financial Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
2,020
+32
| +2% | +$5.94K | 0.12% | 102 |
|
|
2025
Q1 | $417K | Buy |
1,988
+401
| +25% | +$84K | 0.14% | 87 |
|
|
2024
Q4 | $282K | Sell |
1,587
-821
| -34% | -$146K | 0.1% | 121 |
|
|
2024
Q3 | $476K | Buy |
2,408
+187
| +8% | +$36.9K | 0.17% | 82 |
|
|
2024
Q2 | $381K | Buy |
2,221
+222
| +11% | +$38.1K | 0.15% | 92 |
|
|
2024
Q1 | $364K | Buy |
1,999
+124
| +7% | +$22.6K | 0.16% | 98 |
|
|
2023
Q4 | $291K | Buy |
1,875
+196
| +12% | +$30.4K | 0.14% | 105 |
|
|
2023
Q3 | $250K | Buy |
1,679
+136
| +9% | +$20.3K | 0.13% | 103 |
|
|
2023
Q2 | $208K | Buy |
1,543
+2
| +0.1% | +$269 | 0.11% | 113 |
|
|
2023
Q1 | $246K | Hold |
1,541
| – | – | 0.13% | 100 |
|
|
2022
Q4 | $249K | Buy |
+1,541
| New | +$249K | 0.14% | 98 |
|
|
2022
Q2 | – | Sell |
-1,420
| Closed | -$230K | – | 113 |
|
|
2022
Q1 | $230K | Buy |
+1,420
| New | +$230K | 0.13% | 100 |
|
|
2017
Q3 | $223K | Buy |
+2,512
| New | +$223K | 0.2% | 70 |
|